We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTON icon
351
Peloton Interactive
PTON
$2.85B
– –
-113,093
Closed -$529K
QS icon
352
QuantumScape Corp
QS
$3.05B
– –
-47,893
Closed -$275K
RDN icon
353
Radian Group
RDN
$5.28B
– –
-16,147
Closed -$560K
REI icon
354
Ring Energy
REI
$307M
– –
-354,659
Closed -$567K
RGEN icon
355
Repligen
RGEN
$6.91B
– –
-1,418
Closed -$211K
RICK icon
356
RCI Hospitality Holdings
RICK
$202M
– –
-11,627
Closed -$518K
RIOT icon
357
Riot Platforms
RIOT
$6.9B
– –
-82,063
Closed -$609K
RKT icon
358
Rocket Companies
RKT
$38.8B
– –
-12,347
Closed -$237K
RMBS icon
359
Rambus
RMBS
$8.98B
– –
-8,230
Closed -$347K
RMD icon
360
ResMed
RMD
$31.1B
– –
-2,933
Closed -$716K
RMR icon
361
The RMR Group
RMR
$335M
– –
-18,170
Closed -$461K
RSG icon
362
Republic Services
RSG
$67.4B
– –
-3,771
Closed -$757K
RTX icon
363
RTX Corp
RTX
$290B
– –
-2,285
Closed -$277K
RUN icon
364
Sunrun
RUN
$2.26B
– –
-23,300
Closed -$421K
RYAN icon
365
Ryan Specialty Holdings
RYAN
$6.02B
– –
-4,082
Closed -$271K
S icon
366
SentinelOne
S
$6.35B
– –
-20,911
Closed -$500K
SAIC icon
367
Saic
SAIC
$4.95B
– –
-4,650
Closed -$648K
SAM icon
368
Boston Beer
SAM
$1.95B
– –
-3,876
Closed -$1.12M
SBRA icon
369
Sabra Healthcare REIT
SBRA
$5.56B
– –
-23,848
Closed -$444K
SBR
370
Sabine Royalty Trust
SBR
$1.06B
– –
-6,234
Closed -$385K
SBUX icon
371
Starbucks
SBUX
$119B
– –
-5,665
Closed -$552K
SCS
372
DELISTED
Steelcase
SCS
– –
-77,692
Closed -$1.05M
SEM
373
DELISTED
Select Medical
SEM
– –
-26,869
Closed -$505K
SFBS
374
ServisFirst Bancshares
SFBS
$4.9B
– –
-4,669
Closed -$376K
SGRY icon
375
Surgery Partners
SGRY
$2.15B
– –
-1,780,287
Closed -$57.4M
13 14
15
16 17

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.